Supernus Announces that its Partner Shire Receives FDA Approval for Mydayis™ for ADHD Read more about Supernus Announces that its Partner Shire Receives FDA Approval for Mydayis™ for ADHD
Supernus to Present at Jefferies Healthcare Conference Read more about Supernus to Present at Jefferies Healthcare Conference
Supernus Announces First Quarter 2017 Financial Results Read more about Supernus Announces First Quarter 2017 Financial Results
Supernus to Host First Quarter 2017 Earnings Conference Call Read more about Supernus to Host First Quarter 2017 Earnings Conference Call
Supernus Receives Final FDA Approval for Trokendi XR® for Migraine Prophylaxis in Adults and Adolescents Read more about Supernus Receives Final FDA Approval for Trokendi XR® for Migraine Prophylaxis in Adults and Adolescents
Supernus Announces Settlement with Actavis on Trokendi XR® Patent Litigation Read more about Supernus Announces Settlement with Actavis on Trokendi XR® Patent Litigation
Supernus Announces Settlement with Zydus on Trokendi XR® Patent Litigation Read more about Supernus Announces Settlement with Zydus on Trokendi XR® Patent Litigation
Supernus Announces Record Fourth Quarter and Full Year 2016 Financial Results Read more about Supernus Announces Record Fourth Quarter and Full Year 2016 Financial Results
Supernus to Present at Cowen Health Care Conference in March Read more about Supernus to Present at Cowen Health Care Conference in March
Supernus to Host Fourth Quarter and Full Year 2016 Earnings Conference Call Read more about Supernus to Host Fourth Quarter and Full Year 2016 Earnings Conference Call